SLENYTO® (melatonin extended-release tablets) is now available in Canada as a prescription treatment for insomnia in children and adolescents with autism spectrum disorder (ASD) and/or Smith-Magenis ...

Hetlioz (tasimelteon) will not gain an expanded EU indication for Smith-Magenis syndrome after the European Medicines Agency (EMA) upheld its earlier rejection following reexamination. The rejected ...